Skip to main content
Premium Trial:

Request an Annual Quote

New Products Posted to GenomeWeb: Genoptix, Asuragen

Genoptix BCR-ABL MRDx TFR Monitoring Test

Genoptix has released its BCR-ABL MRDx TFR Monitoring Test for patients with chronic myeloid leukemia being treated with Tasigna. According to the firm, the assay is the only diagnostic test authorized by the US Food and Drug Administration for managing patients on tyrosine kinase inhibitors.

Asuragen QuantideX NGS Data Hotspot 21 RUO Kit

Asuragen has launched its QuantideX NGS DNA Hotspot 21 Kit, a targeted next-generation sequencing panel to detect variants across several tumor types. The assay, which runs on the Illumina MiSeq, screens for the most commonly observed variants. The kit provides the reagents needed to prepare sequencing-ready libraries in as little as 24 hours, and the firm's bioinformatics software examines whether enough amplifiable DNA exists. 

For more new products and services, please visit the New Products page on our website.